Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effectiveness and Safety of Sublingual MM09 for Patients Aged 12-65 with Allergies to House Dust Mites and Rhinitis/Rhinoconjunctivitis with or without Asthma

    Recruiting

    3 1
    Portugal Spain
  • Study of Efgartigimod PH20 SC for Children Aged 2 to 17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Italy The Netherlands +2
  • Long-Term Safety Study of Gene Therapy with Etuvetidigene Autotemcel for Patients with Wiskott-Aldrich Syndrome

    Recruiting

    2 1 1
    Investigated Drugs:
    France
  • Study of tovorafenib (DAY101) in children and young adults aged 6 months to 25 years with brain tumors and other solid tumors that have RAF gene changes

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Germany The Netherlands
  • Study on Metformin for Patients with Osteosarcoma and Ewing’s Sarcoma at High Risk of Relapse

    Recruiting

    2 1 1 1
    Italy
  • Study on Long-term Safety of Vedolizumab and Prednisone in Children with Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Croatia Greece Hungary Italy Poland
  • Study of Mirikizumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Italy The Netherlands Norway +3
  • Study comparing prophylactic versus selective surfactant (poractant alfa, phospholipid fraction) administration in preterm infants with respiratory distress syndrome aged 25-30 weeks

    Recruiting

    3 1 1 1
    Germany
  • Study on Allopurinol Sodium for Brain Injury Prevention in Newborns with Critical Congenital Heart Disease Undergoing Heart Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Long-Term Safety Study of Dabrafenib Mesylate and Trametinib Dimethyl Sulfoxide for Patients Benefiting from Previous Treatment in Multiple Indications

    Recruiting

    3 1 1 1
    Austria Czechia Denmark France Germany Hungary +2